Literature DB >> 16166134

Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.

Alfonso Gutiérrez-Macías1, Eva Lizarralde-Palacios, Pedro Martínez-Odriozola, Felipe Miguel-De la Villa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16166134      PMCID： PMC1215560          DOI： 10.1136/bmj.331.7517.623

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  The drug hypersensitivity syndrome: what is the pathogenesis?

Authors:  J R Sullivan; N H Shear
Journal:  Arch Dermatol       Date:  2001-03

Review 2.  Controversy in primary care: Should asymptomatic haemochromatosis be treated?

Authors:  C J Seamark; M Hutchinson
Journal:  BMJ       Date:  2000-05-13

3.  Allopurinol hypersensitivity syndrome.

Authors:  Bryan E Anderson; David R Adams
Journal:  J Drugs Dermatol       Date:  2002-07       Impact factor: 2.114

4.  DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome.

Authors:  R D Sontheimer; K R Houpt
Journal:  Arch Dermatol       Date:  1998-07

Review 5.  Allopurinol hypersensitivity syndrome: a review.

Authors:  F Arellano; J A Sacristán
Journal:  Ann Pharmacother       Date:  1993-03       Impact factor: 3.154

6.  Allopurinol, erythema multiforme, and renal insufficiency.

Authors:  A Kumar; N Edward; M I White; P W Johnston; G R Catto
Journal:  BMJ       Date:  1996-01-20

Review 7.  Cutaneous and systemic manifestations of drug-induced vasculitis.

Authors:  Sandra M ten Holder; Melanie S Joy; Ronald J Falk
Journal:  Ann Pharmacother       Date:  2002-01       Impact factor: 3.154

Review 8.  Human herpesvirus 6 and drug allergy.

Authors:  Koji Hashimoto; Masataka Yasukawa; Mikiko Tohyama
Journal:  Curr Opin Allergy Clin Immunol       Date:  2003-08

9.  The allopurinol hypersensitivity syndrome.

Authors:  G P Lupton; R B Odom
Journal:  J Am Acad Dermatol       Date:  1979-10       Impact factor: 11.527

10.  The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality.

Authors:  J Z Singer; S L Wallace
Journal:  Arthritis Rheum       Date:  1986-01
View more
  22 in total

1.  Drug-related deaths: an analysis of the Italian spontaneous reporting database.

Authors:  Roberto Leone; Laura Sottosanti; Maria Luisa Iorio; Carmela Santuccio; Anita Conforti; Vilma Sabatini; Ugo Moretti; Mauro Venegoni
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 2.  Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue.

Authors:  Chun Hu; Xiaoyan Wu
Journal:  Int Urol Nephrol       Date:  2019-08-28       Impact factor: 2.370

3.  Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry.

Authors:  L Pasina; A L Brucato; C D Djade; P Di Corato; S Ghidoni; M Tettamanti; C Franchi; F Salerno; S Corrao; A Marengoni; M Marcucci; P M Mannucci; A Nobili
Journal:  Eur J Clin Pharmacol       Date:  2014-09-18       Impact factor: 2.953

4.  Combined effect of hyperuricemia and overweight/obesity on the prevalence of hypertension among US adults: result from the National Health and Nutrition Examination Survey.

Authors:  G-M Han; S Gonzalez; D DeVries
Journal:  J Hum Hypertens       Date:  2014-05-01       Impact factor: 3.012

Review 5.  New developments in clinically relevant mechanisms and treatment of hyperuricemia.

Authors:  Susan J Lee; Robert A Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

6.  The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort.

Authors:  Hadar Duskin-Bitan; Eytan Cohen; Elad Goldberg; Tzippy Shochat; Amos Levi; Moshe Garty; Ilan Krause
Journal:  Clin Rheumatol       Date:  2014-02-13       Impact factor: 2.980

Review 7.  Gout: optimizing treatment to achieve a disease cure.

Authors:  José Antonio Bernal; Neus Quilis; Mariano Andrés; Francisca Sivera; Eliseo Pascual
Journal:  Ther Adv Chronic Dis       Date:  2016-01-12       Impact factor: 5.091

Review 8.  Allopurinol hypersensitivity: investigating the cause and minimizing the risk.

Authors:  Lisa K Stamp; Richard O Day; James Yun
Journal:  Nat Rev Rheumatol       Date:  2015-09-29       Impact factor: 20.543

9.  Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre.

Authors:  Annie Pierre Jonville-Béra; Hassan Saissi; Lamiae Bensouda-Grimaldi; Frederique Beau-Salinas; Haware Cissoko; Bruno Giraudeau; Elisabeth Autret-Leca
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Xanthine Oxidoreductase Inhibitors.

Authors:  Keeran Vickneson; Jacob George
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.